MEG3 |
PRC2 |
Targets the cis or trans of PRC2 to mediate H3K27 methylation and gene silencing for dosage compensation, imprinting, and developmental gene expression |
29 |
LRP1-AS |
HMGB2 |
Modulate the activity of non-histone chromatin modifier HMGB2 to decrease the expression of LRP1 |
31 |
H19 |
DNMT3B |
Prevent DNMT3B from DNA methylation through attenuating SAHH hydrolysis to SAH |
32 |
Kcnq1ot1 and Airn |
G9a |
Targets H3K9 methylase G9a for imprinting |
33, 34
|
Xist |
PCR1 |
Recruit epigenetic complexes to change the status of histones and DNA, and then inactive X chromatin |
35, 36
|
MLN |
SERCA |
Interact with SERCA and impede Ca2+ uptake into the SR |
12 |
SPAR |
mTORC1 |
Bind to v-ATPase and blunts mTORC1 activation by amino acids |
39 |
HOXB-AS3 peptide |
PKM, miR-18 |
Inhibit tumorigenesis by blocking PKM splicing, PKM2 formation, miR-18a processing, and subsequent metabolic reprogramming in colon cancer (CRC) cells |
40 |